SBTi Registry
Explore 1 matching companies with public, verified Science Based Targets commitments.
Data sourced from the Science Based Targets initiative (SBTi).
Show
20
per page| Sector | Region | Near-Term Status | Size | ||||
|---|---|---|---|---|---|---|---|
| ACETO US LLC dba ACTYLIS | Pharmaceuticals, Biotechnology and Life Sciences | Northern America | Targets set | Medium | 1 | Oct 16, 2025 | |
Near-Term Status Targets set Near-Term Classification 1.5°C Near-Term Target Year 2035 Long-Term Status - Net-Zero Status Commitment removed Net-Zero Year - Sector Pharmaceuticals, Biotechnology and Life Sciences Region Northern America Organization Type Corporate Location United States of America Company Size Medium Target Statement Near-Term Targets: ACETO US LLC dba ACTYLIS commits to reduce absolute scope 1 and 2 GHG emissions 63.0% by 2035 from a 2024 base year. ACETO US LLC dba ACTYLIS also commits to reduce absolute scope 3 GHG emissions 37.5% within the same timeframe. Stakeholders Chief Sustainability Officer / Chief Supplier Management Officer | |||||||
Show
20
per pageTurn Commitments Into Impact
Thousands of companies have set public Scope 3 emissions-reduction targetsthrough SBTi, but few have the tools to deliver on them. Carbon3 gives you the infrastructure to plan, track, and execute the supply-chain decarbonization work behind your commitment, turning a public pledge into measurable progress. See how it works.